Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06343311
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-03-14
Brief Title:
T-Cell Therapy EB103 in Adults With RelapsedRefractory B-Cell Non-Hodgkins Lymphoma NHL
Sponsor:
Organization:
Estrella Immunopharma Inc